RichardGGorlickMD

PubMed

• Genetically inferred birthweight, height, and puberty timing and risk of osteosarcoma.
  D Matthew Gianferante, Amy Moore, Logan G Spector, William Wheeler, Tianzhong Yang, Aubrey Hubbard, Richard Gorlick, Ana Patiño-Garcia, Fernando Lecanda, Adrienne M Fl...> ;Cancer Epidemiology. 2023 Aug 16
• 9 citations
  Randomized Phase III Trial of Ganitumab With Interval-Compressed Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma: A Report From the Children's ...
  DuBois, S., Krailo, M., Glade-Bender, J., Buxton, A., Laack, N., Randall, R., Chen, H., Seibel, N., Boron, M., Terezakis, S., Hill-Kayser, C., Hayes, A., Reid, J., Teo...> ;Journal of Clinical Oncology. 2023 Apr 10
• 1 citations
  A phase I trial of metformin in combination with vincristine, irinotecan, and temozolomide in children with relapsed or refractory solid and central nervous system tum...
  Jonathan L Metts, Matteo Trucco, Daniel A Weiser, Patrick Thompson, Eric Sandler, Tiffany Smith, Jessica Crimella, Samer Sansil, Ram Thapa, Brooke L Fridley, Nicholas ...> ;Cancer Medicine. 2023 Feb 1
• 4 citations
  Examining Stripes on a Herd of Zebras: Impact of Genomic Matching for Ultrarare Sarcomas in Phase 1 Clinical Trials (SAMBA 102).
  Justin T Moyers, Roberto Carmagnani Pestana, Jason Roszik, David S Hong, Aung Naing, Siqing Fu, Sarina Piha-Paul, Timothy A Yap, Daniel Karp, Jordi Rodon, Andy Livings...> ;Clinical Cancer Research. 2023 Jan 17
• 1 citations
  Author Correction: Osteosarcoma.
  Hannah C Beird, Stefan S Bielack, Adrienne M Flanagan, Jonathan Gill, Dominique Heymann, Katherine A Janeway, J Andrew Livingston, Ryan D Roberts, Sandra J Strauss, Ri...> ;Nature Reviews. Disease Primers. 2022 Dec 30
• 51 citations
  Osteosarcoma.
  Hannah C Beird, Stefan S Bielack, Adrienne M Flanagan, Jonathan Gill, Dominique Heymann, Katherine A Janeway, J Andrew Livingston, Ryan D Roberts, Sandra J Strauss, Ri...> ;Nature Reviews. Disease Primers. 2022 Dec 8
• 17 citations
  An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma.
  Shulman, D., Whittle, S., Surdez, D., Bailey, K., de Álava, E., Yustein, J., Shlien, A., Hayashi, M., Bishop, A., Crompton, B., DuBois, S., Shukla, N., Leavey, P., Les...> ;NPJ Precision Oncology. 2022 Sep 17
• 11 citations
  Phase 2 study of anti-disialoganglioside antibody, dinutuximab, in combination with GM-CSF in patients with recurrent osteosarcoma: A report from the Children's Oncolo...
  Pooja Hingorani, Mark Krailo, Allen Buxton, Paul Hutson, Paul M Sondel, Mitchell Diccianni, Alice Yu, Carol D Morris, Richard B Womer, Brian Crompton, R Lor Randall, L...> ;European Journal of Cancer. 2022 Sep 1
• 4 citations
  Membrane-Anchored and Tumor-Targeted IL12 (attIL12)-PBMC Therapy for Osteosarcoma.
  Qing Yang, Jiemiao Hu, Zhiliang Jia, Qi Wang, Jing Wang, Long Hoang Dao, Wendong Zhang, Sheng Zhang, Xueqing Xia, Richard Gorlick, Shulin Li> ;Clinical Cancer Research. 2022 Sep 1
• 6 citations
  Trastuzumab Deruxtecan, Antibody-Drug Conjugate Targeting HER2, Is Effective in Pediatric Malignancies: A Report by the Pediatric Preclinical Testing Consortium.
  Pooja Hingorani, Wendong Zhang, Zhongting Zhang, Zhaohui Xu, Wei-Lien Wang, Michael E Roth, Yifei Wang, Jonathan B Gill, Douglas J Harrison, Beverly A Teicher, Stephen...> ;Molecular Cancer Therapeutics. 2022 Aug 2
• 4 citations
  Analysis of Local Control Outcomes and Clinical Prognostic Factors in Localized Pelvic Ewing Sarcoma Patients Treated With Radiation Therapy: A Report From the Childre...
  Safia K Ahmed, Brent G Witten, William S Harmsen, Peter S Rose, Mark Krailo, Karen J Marcus, R Lor Randall, Steven G DuBois, Katherine A Janeway, Richard B Womer, Holc...> ;International Journal of Radiation Oncology, Biology, Physics. 2023 Feb 1
• 9 citations
  Comprehensive Surfaceome Profiling to Identify and Validate Novel Cell-Surface Targets in Osteosarcoma.
  Yifei Wang, Xiangjun Tian, Wendong Zhang, Zhongting Zhang, Rossana Lazcano, Pooja Hingorani, Michael E Roth, Jonathan D Gill, Douglas J Harrison, Zhaohui Xu, Sylvester...> ;Molecular Cancer Therapeutics. 2022 Jun 1
• 14 citations
  Cell membrane-anchored and tumor-targeted IL-12 (attIL12)-T cell therapy for eliminating large and heterogeneous solid tumors.
  Jiemiao Hu, Qing Yang, Wendong Zhang, Hongwei Du, Yuhui Chen, Qingnan Zhao, Long Dao, Xueqing Xia, Fowlkes Natalie Wall, Zhongting Zhang, Kris Mahadeo, Richard Gorlick...> ;Journal for Immunotherapy of Cancer. 2022 Jan 1
• 32 citations
  Phase III Trial Adding Vincristine-Topotecan-Cyclophosphamide to the Initial Treatment of Patients With Nonmetastatic Ewing Sarcoma: A Children's Oncology Group Report
  Patrick J. Leavey, Nadia N. Laack, Mark Krailo, Allen Buxton, R. Lor Randall, Steven G. DuBois, Damon R. Reed, Holcombe E. Grier, Douglas S. Hawkins, Bruce R. Pawel, H...> ;Journal of Clinical Oncology. 2021 Oct 15
• 6 citations
  Outcome of patients with relapsed or progressive Ewing sarcoma enrolled on cooperative group phase 2 clinical trials: A report from the Children's Oncology Group
  Anderson B. Collier, Mark Krailo, Ha Dang, Steven G. DuBois, Douglas S. Hawkins, Mark L. Bernstein, Lisa Bomgaars, Damon R. Reed, Richard Gorlick, Katherine A. Janeway> ;Pediatric Blood & Cancer. 2021 Dec 1
• 11 citations
  In vivo evaluation of the lysine-specific demethylase (KDM1A/LSD1) inhibitor SP-2577 (Seclidemstat) against pediatric sarcoma preclinical models: A report from the Ped...
  Raushan T. Kurmasheva, Stephen W. Erickson, Ruolan Han, Beverly A. Teicher, Malcolm A. Smith, Michael Roth, Richard Gorlick, Peter J. Houghton> ;Pediatric Blood & Cancer. 2021 Aug 28
• 6 citations
  Charting a path for prioritization of novel agents for clinical trials in osteosarcoma: A report from the Children's Oncology Group New Agents for Osteosarcoma Task Fo...
  Sarah B. Whittle, Katharine Offer, Ryan D. Roberts, Amy K. LeBlanc, Cheryl A. London, Robbie G. Majzner, Alex Yee-Chen Huang, Peter J. Houghton, E. Alejandro Sweet Cor...> ;Pediatric Blood & Cancer. 2021 Jun 16
• 255 citations
  Advancing therapy for osteosarcoma.
  Jonathan Gill, Richard Gorlick> ;Nature Reviews. Clinical Oncology. 2021 Jun 15
• 8 citations
  Wnt/ß-catenin-mediated p53 suppression is indispensable for osteogenesis of mesenchymal progenitor cells.
  Xin Zhou, Allyson Beilter, Zhaohui Xu, Ruli Gao, Shunbin Xiong, Adriana Paulucci-Holthauzen, Guillermina Lozano, Benoit de Crombrugghe, Richard Gorlick> ;Cell Death & Disease. 2021 May 21
• 3 citations
  Patterns of Translocation Testing in Patients Enrolling to a Cooperative Group Trial for Newly Diagnosed Metastatic Ewing Sarcoma: A Report From the Children's Oncolog...
  Steven G. DuBois, Mark Krailo, Allen Buxton, Stephen L. Lessnick, Lisa A. Teot, Dinesh Rakheja, Brian D. Crompton, Katherine A. Janeway, Richard Gorlick, Julia Glade-B...> ;Archives of Pathology & Laboratory Medicine. 2021 Dec 1
• 50 citations
  The B7-H3-Targeting Antibody-Drug Conjugate m276-SL-PBD Is Potently Effective Against Pediatric Cancer Preclinical Solid Tumor Models.
  Nathan M. Kendsersky, Jarrett M. Lindsay, E. Anders Kolb, Malcolm A. Smith, Beverly A. Teicher, Stephen W. Erickson, Eric J. Earley, Yael P. Mosse, Daniel Martinez, Je...> ;Clinical Cancer Research. 2021 Feb 22
• 11 citations
  The interaction of SKP2 with p27 enhances the progression and stemness of osteosarcoma
  Jichuan Wang, Osama Aldahamsheh, Alexander Ferrena, Hasibagan Borjihan, Amit Singla, Simon Yaguare, Swapnil Singh, Valentina Viscarret, Janet Tingling, Xiaolin Zi, Yun...> ;Annals of the New York Academy of Sciences. 2021 Apr 1
• 7 citations
  Prognostic and Therapeutic Utility of Variably Expressed Cell Surface Receptors in Osteosarcoma.
  Yoav Zvi, Elif Ugur, Brian Batko, Jonathan Gill, Michael Roth, Richard Gorlick, David Hall, Janet Tingling, Donald A. Barkauskas, Jinghang Zhang, Rui Yang, Bang H. Hoa...> ;Sarcoma. 2021 Feb 2
• 13 citations
  Transcriptional activators YAP/TAZ and AXL orchestrate dedifferentiation, cell fate, and metastasis in human osteosarcoma
  , , , , , , , , , , , , , , , , , , > ;Cancer Gene Therapy. 2021 Jan 6
• 5 citations
  Prognostic Value of Cell-Surface Vimentin-Positive CTCs in Pediatric Sarcomas.
  Long Dao, Dristhi Ragoonanan, Izhar Batth, Arun Satelli, Jessica Foglesong, Jian Wang, Wafik Zaky, Jonathan B Gill, Diane Liu, Aisha Albert, Nancy Gordon, Winston Huh,...> ;Frontiers in Oncology. 2021 Jan 1
• Join now to see all

Journal Articles

• Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients with Osteosarcoma  
  Richard Gorlick, MD, JAMA Oncology
• Future directions in the treatment of osteosarcoma  
  Bishop MW, Janeway KA, Gorlick R, Curr Opin Pediatr, 1/1/2016
• Transcriptional Profiling Identifies the Signaling Axes of IGF and Transforming Growth Factor-b as Involved in the Pathogenesis of Osteosarcoma  
  Yang R, Piperdi S, Zhang Y, Zhu Z, Neophytou N, Hoang BH, Mason G, Geller D, Dorfman H, Meyers PA, Healey JH, Phinney DG, Gorlick R, Clin Orthop Relat Res, 1/1/2016
• A RUNX2-Mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells  
  Shin MH, He Y, Marrogi E, Piperdi S, Ren L, Khanna C, Gorlick R, Liu C, Huang J, PLoS Genet, 1/1/2016
• Pharmacodynamic and genomic markers associated with response to the XPO1/CRM1 inhibitor selinexor (KPT-330): A report from the pediatric preclinical testing program  
  Attiyeh EF, Maris JM, Lock R, Reynolds CP, Kang MH, Carol H, Gorlick R, Kolb EA, Keir ST, Wu J, Landesman Y, Shacham S, Lyalin D, Kurmasheva RT, Houghton PJ, Smith MA, Pediatr Blood Cancer, 1/1/2016
• Assessment of extent of surgical resection of primary high-grade osteosarcoma by treating institutions: A report from the Children's Oncology Group  
  Morris CD, Teot LA, Bernstein ML, Marina N, Krailo MD, Villaluna D, Janeway KA, DuBois SG, Gorlick RG, Randall RL, J Surg Oncol, 1/1/2016
• Initial Testing of NSC 750854, a Novel Purine Analog, Against Pediatric Tumor Models by the Pediatric Preclinical Testing Program  
  Gorlick R, Kolb EA, Keir ST, Maris JM, Lock RB, Carol H, Reynolds CP, Kang MH, Billups CA, Collins J, Kurmashev D, Kurmasheva RT, Houghton PJ, Smith MA, Pediatr Blood Cancer, 1/1/2016
• Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma  
  Koirala P, Roth ME, Gill J, Piperdi S, Chinai JM, Geller DS, Hoang BH, Park A, Fremed MA, Zang X, Gorlick R, Sci Rep, 1/1/2016
• Impact of Two Measures of Micrometastatic Disease on Clinical Outcomes in Patients with Newly Diagnosed Ewing Sarcoma: A Report from the Children's Oncology Group  
  Vo KT, Edwards JV, Epling CL, Sinclair E, Hawkins DS, Grier HE, Janeway KA, Barnette P, McIlvaine E, Krailo MD, Barkauskas DA, Matthay KK, Womer RB, Gorlick RG, Lessni..., Clin Cancer Res, 1/1/2016
• HHLA2, a member of the B7 family, is expressed in human osteosarcoma and is associated with metastases and worse survival  
  Koirala P, Roth ME, Gill J, Chinai JM, Ewart MR, Piperdi S, Geller DS, Hoang BH, Fatakhova YV, Ghorpade M, Zang X, Gorlick R, Sci Rep, 1/1/2016
• Outcome of Patients With Recurrent Osteosarcoma Enrolled in Seven Phase II Trials Through Children's Cancer Group, Pediatric Oncology Group, and Children's Oncology Gr...  
  Lagmay JP, Krailo MD, Dang H, Kim A, Hawkins DS, Beaty O, Widemann BC, Zwerdling T, Bomgaars L, Langevin AM, Grier HE, Weigel B, Blaney SM, Gorlick R, Janeway KA, J Clin Oncol, 1/1/2016
• A phase II study of clinical activity of SCH 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcoma  
  Anderson PM, Bielack SS, Gorlick RG, Skubitz K, Daw NC, Herzog CE, Monge OR, Lassaletta A, Boldrini E, P�pai Z, Rubino J, Pathiraja K, Hille DA, Ayers M, Yao SL, Neboz..., Pediatr Blood Cancer, 1/1/2016
• Assessing the Prognostic Significance of Histologic Response in Osteosarcoma: A Comparison of Outcomes on CCG-782 and INT0133-A Report From the Children's Oncology Gro...  
  Bishop MW, Chang YC, Krailo MD, Meyers PA, Provisor AJ, Schwartz CL, Marina NM, Teot LA, Gebhardt MC, Gorlick R, Janeway KA, Chou AJ, Pediatr Blood Cancer, 1/1/2016
• Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, in...  
  Marina NM, Smeland S, Bielack SS, Bernstein M, Jovic G, Krailo MD, Hook JM, Arndt C, van den Berg H, Brennan B, Brichard B, Brown KL, Butterfass-Bahloul T, Calaminus G..., Lancet Oncol, 1/1/2016
• Evaluation of Alternative In Vivo Drug Screening Methodology: A Single Mouse Analysis  
  Murphy B, Yin H, Maris JM, Kolb EA, Gorlick R, Reynolds CP, Kang MH, Keir ST, Kurmasheva RT, Dvorchik I, Wu J, Billups CA, Boateng N, Smith MA, Lock RB, Houghton PJ, Cancer Res, 1/1/2016
• Local Control Modality and Outcome for Ewing Sarcoma of the Femur: A Report From the Children's Oncology Group  
  Daw NC, Laack NN, McIlvaine EJ, Krailo M, Womer RB, Granowetter L, Grier HE, Marina NM, Bernstein ML, Gebhardt MC, Marcus KJ, Advani SM, Healey JH, Letson GD, Gorlick ..., Ann Surg Oncol, 1/1/2016
• Targeted therapy of osteosarcoma with radiolabeled monoclonal antibody to an insulin-like growth factor-2 receptor (IGF2R)  
  Geller DS, Morris J, Revskaya E, Kahn M, Zhang W, Piperdi S, Park A, Koirala P, Guzik H, Hall C, Hoang B, Yang R, Roth M, Gill J, Gorlick R, Dadachova E, Nucl Med Biol, 1/1/2016
• Osteosarcoma: Current Treatment and a Collaborative Pathway to Success  
  Isakoff MS, Bielack SS, Meltzer P, Gorlick R, J Clin Oncol, 1/1/2015
• EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment  
  Whelan JS, Bielack SS, Marina N, Smeland S, Jovic G, Hook JM, Krailo M, Anninga J, Butterfass-Bahloul T, B�hling T, Calaminus G, Capra M, Deffenbaugh C, Dhooge C, Erik..., Ann Oncol, 1/1/2015
• Synergistic activity of PARP inhibition by talazoparib (BMN 673) with temozolomide in pediatric cancer models in the pediatric preclinical testing program  
  Smith MA, Reynolds CP, Kang MH, Kolb EA, Gorlick R, Carol H, Lock RB, Keir ST, Maris JM, Billups CA, Lyalin D, Kurmasheva RT, Houghton PJ, Clin Cancer Res, 1/1/2015
• A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis  
  Moriarity BS, Otto GM, Rahrmann EP, Rathe SK, Wolf NK, Weg MT, Manlove LA, LaRue RS, Temiz NA, Molyneux SD, Choi K, Holly KJ, Sarver AL, Scott MC, Forster CL, Modiano ..., Nat Genet, 1/1/2015
• Germline TP53 variants and susceptibility to osteosarcoma  
  Mirabello L, Yeager M, Mai PL, Gastier-Foster JM, Gorlick R, Khanna C, Pati�o-Garcia A, Sierrases�maga L, Lecanda F, Andrulis IL, Wunder JS, Gokgoz N, Barkauskas DA, Z..., J Natl Cancer Inst, 1/1/2015
• Initial testing (stage 1) of the tubulin binding agent nanoparticle albumin-bound (nab) paclitaxel (Abraxane(�)) by the Pediatric Preclinical Testing Program (PPTP)  
  Houghton PJ, Kurmasheva RT, Kolb EA, Gorlick R, Maris JM, Wu J, Tong Z, Arnold MA, Chatterjee M, Williams TM, Smith MA, Pediatr Blood Cancer, 1/1/2015
• Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and G...  
  Bielack SS, Smeland S, Whelan JS, Marina N, Jovic G, Hook JM, Krailo MD, Gebhardt M, P�pai Z, Meyer J, Nadel H, Randall RL, Deffenbaugh C, Nagarajan R, Brennan B, Lets..., J Clin Oncol, 1/1/2015
• A Genome-Wide Scan Identifies Variants in NFIB Associated with Metastasis in Patients with Osteosarcoma  
  Mirabello L, Koster R, Moriarity BS, Spector LG, Meltzer PS, Gary J, Machiela MJ, Pankratz N, Panagiotou OA, Largaespada D, Wang Z, Gastier-Foster JM, Gorlick R, Khann..., Cancer Discov, 1/1/2015
• Join now to see all

Books/Book Chapters

• Principles and Practice of Pediatric Oncology 
  Chapter: Osteosarcoma: Biology, Diagnosis, Treatment and Remaining Challenge 
  Gorlick R, Bielack S, Teot L, Meyer J, Randall L, Marina NEditors: Pizzo P, Poplack D.Lippincott, Philadelphia, PA2011
• Manual of Pediatric Hematology and Oncology 
  Chapter: Malignant Bone Tumors 
  Dubois S, Janeway K, Gorlick R, Marina NEditors: Lanzkowsky P.Elsevier, Burlington, MAEdition 5th,2011
• Rudolph's Pediatrics 
  Chapter: Osteosarcoma 
  Gorlick R, Meyers PEditors: Rudolph AM, Rudolph C, First L, Lister G, Gershon AA.McGraw-Hill, New York, NYEdition 22nd,2011
• Pediatric Hematology and Oncology 
  Chapter: Bone Tumours 
  Gorlick R, Persioglou M, Whelan JEditors: Estlin E, Gilbertson R, Wynn R.Wiley-Blackwell, Hoboken, NJ2010
• Molecularly Targeted Therapy for Childhood Cancer 
  Chapter: Molecularly Targeted Therapy in Osteosarcoma 
  Ricafort R, Gorlick REditors: Arceci R, Houghton PJ.Springer, New York, NY2010
• Cancer in Children and Adolescents 
  Chapter: Cancer in Children and Adolescents 
  Marina N, Gorlick R, Bielack SEditors: Carroll WL , Finlay JL.Jones & Bartlett, Sudburry, MA2010
• Pediatric and Adolescent Osteosarcoma 
  Chapter: Current Concepts on the Molecular Biology of Osteosarcoma 
  Gorlick REditors: Jaffe N, Bruland OS, Bielack S.Springer, New York, NY2009
• American Academy of Pediatrics Textbook of Pediatric Care 
  Chapter: Leukemias 
  Kolb EA, Gorlick REditors: McInerny TK, Adam HM, Campbell DE, Kamat DK, Kelleher KJ.American Academy of Pediatrics, Elk Grove Village, IL2009
• Nathan and Oski's Oncology of Infancy and Childhood 
  Chapter: Osteosarcoma 
  Janeway K, Gorlick R, Bernstein MLEditors: Orkin SH, Fisher DE, Look AT, Lux SE, Ginsburg D, Nathan DG.Saunders-Elsevier, Philadelphia, PA2009
• Cancer Medicine 
  Chapter: Bone Tumors 
  Gorlick R, Toretsky J, Marina N, Wolden S, Randall RL, Gebhardt M, Teot L, Bernstein MEditors: Holland J, Frei E.BC Decker, Hamilton, OntarioEdition 6th,2003
• Encyclopedia of Cancer 
  Chapter: Bone Tumors 
  Gorlick R, Meyers PAEditors: Bertino JR.Academic Press, San Diego, CAEdition 2nd,2002
• Orthopedic Knowledge Update: Musculoskeletal Tumors 
  Chapter: General Principles of Chemotherapy 
  Meyers PA, Gorlick REditors: Menendez LR.American Academy of Orthopaedic Surgeons, Rosemont, IL2002
• Methotrexate 
  Chapter: Methotrexate, its mechanism of action in malignant disease and mechanisms of resistance by malignant cells 
  Gorlick REditors: Cronstein BN, Bertino JR.Birkh�user Verlag, Basel, Switzerland2000
• Antifolate drugs: Basic research and clinical practice 
  Chapter: Clinical pharmacology and resistance to dihyrdrofolate reductase inhibitors 
  Gorlick R, Bertino JREditors: Jackman AL.The Humana Press, Totowa, NJ1999
• Drug resistance in the treatment of cancer 
  Chapter: Resistance mechanisms to antimetabolites 
  Goker E, Gorlick R, Bertino JREditors: Pinedo H, Giaccone G.Cambridge University Press, Cambridge1998
• Join now to see all

Lectures

• Moving beyond the plateau of outcomes in sarcoma, Current Knowledge and Future Directions in the Treatment of Bone Sarcomas, Focusing on Clinical Trials and Surgical a... 
  Shanghai, China - 1/30/2016
• Beyond the plateau � Scaling new peaks in treating sarcomas! 
  Mumbai, India - 1/14/2015
• Osteosarcoma: Biology and Laboratory Approaches to Identifying New Therapy 
  Tata Memorial Hosptial, Mumbai, India - 1/12/2015
• Osteosarcoma: Children's Oncology Group Clinical Trials 
  New York, NY - 1/3/2015
• Advances in Pediatric Bone Tumors: Osteosarcoma and Ewing Sarcoma 
  New York, NM - 1/2/2015
• Osteosarcoma: Current Status and Potential Routes to Progress 
  Columbia University, New York, NY - 1/28/2014
• Children's Oncology Group Osteosarcoma Phase 2 Clinical Trials 
  Berlin, Germany - 1/16/2014
• Molecular Pathogenesis of Osteosarcoma 
  Bronx, NY - 1/2/2014
• Osteosarcoma: Progress and Vision for Osteosarcoma Therapy 
  St. Jude Children's Cancer Research Hospital, Memphis, TN - 1/13/2013
• Clinical translation in Ewing sarcoma 
  Madrid, Spain - 1/9/2013
• Osteosarcoma: Challenges for Future Progress 
  Texas Children's Hospital, Baylor University, Houston, TX - 1/8/2012
• Pediatric Oncologic Emergencies 
  Jacobi Medical Center and North Central Bronx Hospital, Bronx, NY - 1/6/2012
• Osteosarcoma: Its Biology Needs to Guide its Treatment 
  University Of Medicine And Dentistry Of New Jersey, Robert Wood Johnson Medical School, New Brunswic - 1/17/2011
• Osteosarcoma: Its Biology Needs to Define its New Treatment 
  The Albert Einstein College of Medicine Price Center, LeFrak Auditorium, Bronx, NY - 1/16/2011
• Osteosarcoma: Progress in Biological Understanding and Treatment 
  Stanford University, Stanford, CA - 1/14/2011
• Recognizing and Treating Bone Tumors 
  Jacobi Medical Center and North Central Bronx Hospital, Bronx, NY - 1/8/2011
• Osteosarcoma: Clinical Trials 
  New York, NY - 1/8/2011
• Osteosarcoma: Biology and Therapy 
  The University of Texas MD�Anderson Cancer Center, Children's Cancer Hospital, Houston, TX - 1/8/2010
• Signaling in Pediatric Cancer Comes to the Clinic 
  Chicago, IL - 1/5/2010
• Osteosarcoma: Its Biology Needs to Define New Treatment 
  Georgetown University Hospital and Lombardi Comprehensive Cancer Center, Georgetown, DC - 1/5/2010
• Issues in Understanding the Molecular Biology and Improving Clinical Outcomes of Osteosarcoma 
  The Animal Medical Center, New York, NY - 1/29/2009
• Osteosarcoma: Biology Needs to Define New Therapies 
  Yokohama, Japan - 1/17/2009
• Current Concepts on the Molecular Biology of Osteosarcoma 
  Stuttgart, Germany - 1/14/2009
• Issues in Designing Clinical Studies of the IGF1 Receptor 
  Chicago, IL - 1/30/2008
• Concepts on the Molecular Biology, Drug Resistance and New Therapeutics in Osteosarcoma and New Directions in Osteosarcoma Chemotherapy 
  Seoul, Korea - 1/20/2008
• Join now to see all